Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hammer

Showing results (501-510 of 518) with videos related to

Pageof 52
Sort By:
Nature Communications|January 13, 2026
Biallelic variants in CELSR1 cause brain malformations, neurodevelopmental disorders and epilepsy in humansClaudia M Bonardi, Rikke S Møller, Nuria Ruiz-Reig, et al.
Rheumatology (Oxford, England)|January 16, 2023
Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAMSofia Ramiro, Robert Landewé, Désirée van der Heijde, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 22, 2017
Brief Report: Validation of a Definition of Flare in Patients With Established GoutAngelo L Gaffo, Nicola Dalbeth, Kenneth G Saag, et al.
The Journal of Rheumatology|May 3, 2020
Flare Rate Thresholds for Patient Assessment of Disease Activity States in GoutWilliam Taylor, Nicola Dalbeth, Kenneth G Saag, et al.
JAMA Neurology|February 27, 2018
Efficacy of Exome-Targeted Capture Sequencing to Detect Mutations in Known Cerebellar Ataxia GenesMarie Coutelier, Monia B Hammer, Giovanni Stevanin, et al.
Epilepsia|March 16, 2024
Clinical and molecular characterization of patients with YWHAG-related epilepsyValentina Cetica, Tiziana Pisano, Gaetan Lesca, et al.
Molecular Psychiatry|January 7, 2026
Correction: GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapyJohannes R Lemke, Andrea Eoli, Ilona Krey, et al.
Molecular Psychiatry|October 14, 2025
GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapyJohannes R Lemke, Andrea Eoli, Ilona Krey, et al.
Nature Medicine|January 12, 2021
Modeling human adaptive immune responses with tonsil organoidsLisa E Wagar, Ameen Salahudeen, Christian M Constantz, et al.
American Journal of Industrial Medicine|September 20, 2024
Re: Schulte et al., "An urgent call to address work-related psychosocial hazards and improve worker well-being": It's time to develop a national regulation regarding work-related psychosocial hazardsMarnie Dobson, Pouran Faghri, Paul Landsbergis, et al.
Pageof 52

Showing results (501-510 of 518) with videos related to

Sort By:
Pageof 52
Nature Communications|January 13, 2026
Biallelic variants in CELSR1 cause brain malformations, neurodevelopmental disorders and epilepsy in humansClaudia M Bonardi, Rikke S Møller, Nuria Ruiz-Reig, et al.
Rheumatology (Oxford, England)|January 16, 2023
Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAMSofia Ramiro, Robert Landewé, Désirée van der Heijde, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 22, 2017
Brief Report: Validation of a Definition of Flare in Patients With Established GoutAngelo L Gaffo, Nicola Dalbeth, Kenneth G Saag, et al.
The Journal of Rheumatology|May 3, 2020
Flare Rate Thresholds for Patient Assessment of Disease Activity States in GoutWilliam Taylor, Nicola Dalbeth, Kenneth G Saag, et al.
JAMA Neurology|February 27, 2018
Efficacy of Exome-Targeted Capture Sequencing to Detect Mutations in Known Cerebellar Ataxia GenesMarie Coutelier, Monia B Hammer, Giovanni Stevanin, et al.
Epilepsia|March 16, 2024
Clinical and molecular characterization of patients with YWHAG-related epilepsyValentina Cetica, Tiziana Pisano, Gaetan Lesca, et al.
Molecular Psychiatry|January 7, 2026
Correction: GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapyJohannes R Lemke, Andrea Eoli, Ilona Krey, et al.
Molecular Psychiatry|October 14, 2025
GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapyJohannes R Lemke, Andrea Eoli, Ilona Krey, et al.
Nature Medicine|January 12, 2021
Modeling human adaptive immune responses with tonsil organoidsLisa E Wagar, Ameen Salahudeen, Christian M Constantz, et al.
American Journal of Industrial Medicine|September 20, 2024
Re: Schulte et al., "An urgent call to address work-related psychosocial hazards and improve worker well-being": It's time to develop a national regulation regarding work-related psychosocial hazardsMarnie Dobson, Pouran Faghri, Paul Landsbergis, et al.
Pageof 52